During the past decade, Fukuoka Sanno Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fukuoka Sanno Hospital" #1 sponsor was "Boston Scientific Corporation" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "AstraZeneca" with 1 trials sponsored, "Cook Group Incorporated" with 1 trials sponsored and "Hutchison Medipharma Limited" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

According to Clinical.Site data, the most researched conditions in "Fukuoka Sanno Hospital" are "Asthma" (1 trials), "Atherosclerosis Obliterans" (1 trials), "Atherosclerosis of Native Arteries of the Extremities" (1 trials), "Atrial Fibrillation" (1 trials) and "Buerger Disease" (1 trials). Many other conditions were trialed in "Fukuoka Sanno Hospital" in a lesser frequency.

Most popular intervention types in "Fukuoka Sanno Hospital" are "Drug" (5 trials), "Device" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "3 months of dual antiplatelet therapy (DAPT)" (1 trials), "CLBS12" (1 trials), "ELUVIA (Stent Implantation)" (1 trials), "Lorazepam" (1 trials) and "Paradise™ (PRDS-001) Renal Denervation Ultrasound System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fukuoka Sanno Hospital" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Fukuoka Sanno Hospital". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Fukuoka Sanno Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fukuoka Sanno Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".